Astellas Pharma Europe Ltd. 
Bayer Schering Pharma
GE Healthcare 
Gen-Probe Incorporated 
Invivo 
Ipsen 
Kyowa Hakko Kirin UK Ltd. 
Novartis Oncology 
Wisepress Ltd. 

ASTELLAS PHARMA EUROPE LTD.
Lovett House, Lovett Road, Staines,
Middlesex TW18 3AZ,
United Kingdom
T  :+44 1784 419 400
F  :+44 1784 419 401
W  :www.astellas-europe.co.uk
E  :medical@eu.astellas.com

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas
Pharma Inc. one of the world's top 20 pharmaceutical companies, is a proud sponsor of the 2nd European Multidisciplinary Meeting on Urological Cancers (EMUC). Astellas Pharma Europe is dedicated to improving people's lives around the world through the introduction of innovative and reliable pharmaceutical products. It has key strengths in the therapy areas of Urology, Transplantation, Dermatology and Anti-Infectives. As an
organisation, Astellas is committed to supporting medical research and
education and is a sponsor of a number of key European and national
professional bodies.

BAYER SCHERING PHARMA AG
13342 Berlin, Germany
T  :+49 304 68 11 11
F  :+49 304 68 15 305
W  :www.bayerscheringpharma.de  

Science for a better life - Medical Progress for the Benefit of the Patient.
Bayer Schering Pharma is one of the ten largest specialty pharmaceutical companies in the world and the company's goal is a leading market position in each of its specialist fields. With its distinctive expertise in research, the company develops new medicines and therapies which make an essential contribution toward improving patient's quality of life.
Our outstanding research activities, together with our highly motivated staff, secure the sustainable success and growth of our company. We focus on four business areas, in which we make essential contributions to medical progress.

GE HEALTHCARE
Pollards Wood, Nightingales Lane, HP8 4SP Chalfont St Giles, Bucks, United Kingdom
T  :+ 44 149 45 440 00
F  :+ 44 149 44 982 34
W  :www.gehealthcare.com

GE Healthcare is dedicated to helping you transform healthcare delivery by driving critical breakthroughs in biology and technology. Our expertise in medical imaging and information technologies, diagnostics, patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies is enabling healthcare professionals around the world discover new ways to diagnose and treat disease earlier. We call this model “Early Health”. Our goal is more targeted treatments, so they can help their patients live their lives to the fullest. Re-think, Re-discover, Re-invent, Re-imagine. For additional information, please visit our booth while at EMUC 09.

GEN-PROBE
10210 Genetic Center Drive, San Diego, CA 92121, United States of America
T  :+1 185 852 35001
F  :+1 185 841 08597
W:www.gen-probe.com
E :marketing@gen-probe.com

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used to diagnose human diseases and screen donated human blood. The company also develops and manufactures NATs to detect harmful organisms in the environment and in industrial processes.  Gen-Probe has more than 26 years of NAT expertise, and received the 2004 National Medal of Technology, America’s highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people. For more information, please visit
www.gen-probe.com.

INVIVO
12501 Research Pkwy, Orlando, FL 32826, United States of America
T  :+1 407 275 3220
F  :+1 407 249 2022
W  :www.invivocorp.com
E  :info@invivocorp.com

Invivo introduces the first analysis and interventional system combined to give you an option for a better solution; DynaCAD for Prostate and DynaTRIM.  DynaCAD for Prostate is a digital imaging system with a comprehensive set of advanced visualisation tools for performing real-time image analysis of prostate MRI studies.  DynaTRIM is a first-of-its-kind fully MR compatible interventional device for Trans-Rectal Interventional MR biopsy of the prostate gland.  The new technique takes advantage of the high resolution of MR images and offers the ability to target, under MR guidance, specific suspicious areas in the prostate. For more information, visit www.invivocorp.com or call 800.331.3220.

IPSEN PHARMA
65 Quai Georges Gorse, 92650 Boulogne Billancourt cedex, France
T  :+33 158 33 50 00
F  :+33 158 33 50 01
W  :www.ipsen.com 

Ipsen is an innovation-driven international specialty pharmaceutical group with over 20 products on the market and a total worldwide staff of nearly 4,200. Its development strategy is based on its activities in specialty medicine, growth drivers in targeted therapeutic areas (oncology, endocrinology, neurology and haematology), combined with primary care products which contribute significantly to its research financing. The location of its four Research & Development centres (Paris, Boston, Barcelona, London) and its peptide and protein engineering platform give the Group a competitive edge in gaining access to leading university research teams and highly qualified personnel.

KYOWA HAKKO KIRIN UK LTD
258 Bath Road, Slough, SL1 4DX, Berkshire, England
T  :+44 175 35 66 020
F:+44 175 35 66 030
W:www.kyowa-kirin.co.jp/english
E :medinfo@kyowa-kirin.co.uk 

Kyowa Hakko Kirin is a global specialty pharmaceutical company built on a robust foundation of biotechnology. We are marketing drugs for Oncological use, including Mitomycin-C Kyowa. Mitomycin-C is an essential chemotherapeautic agent in the treatment of non-muscle invasive Bladder Cancer.  Please visit our stand for information on prescribing and new developments.

NOVARTIS ONCOLOGY
180 Park Avenue, 07932 Florham Park, United States of America
T  :+1 862 778 8300
F  :+1 973 781 8265
W  :www.novartisoncology.com
E  :judith.federhofer@novartis.com 
 
Novartis Oncology delivers a broad range of innovative therapies aimed at improving and extending the lives of patients. These include Glivec (R) (imatinib), Tasigna (r) (nilotinib), Exjade (R) (deferasirox), Zometa (R) (zoledronic acid), Sandostatin (R) LAR (R) (octreotide/IM injection) and femara (R) (letrozole). Novartis Oncology has a robust pipeline capitalising on recent discoveries in molecular genomics, rational drug design and state-of-the-art drug discovery technologies.

WISEPRESS MEDICAL BOOKSHOP
The Old Lamp Works, 25 High Path Merton Abbey, SW19 2JL London, United Kingdom
T  :+44 208 71 518 12
F  :+44 208 71 517 22
W  :www.wisepress.com
E  :bookshop@wisepress.com

Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 250 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers, some up to 40% off the publisher list prices.